Cite
HARVARD Citation
Iughetti, L. et al. (2016). Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study. Italian journal of pediatrics. 42 (1), pp. 1-7. [Online].